Cannabis Market Expected to Explode For CBD Based Medicines and Products As Farm Hemp Bill Passing Nears

Cannabis Market Expected to Explode For CBD Based Medicines and Products As Farm Hemp Bill Passing Nears

Palm Beach, FL – (December 13, 2018) – The expected imminent passing of the Farm Hemp Bill is projected to provide a significant boost to the cannabis market as hemp will become effectively legalized, allowing for increased production and support for cannabis farmers. A much anticipated end to hemp prohibition has been approved by a House-Senate panel, potentially opening the door to hemp production in all 50 states for any use, but especially opening the doors for CBD based medicines and consumer products. The measure is included in the 2018 Farm Bill, which passed the Senate 87-13 on Tuesday and still must pass the House before work is concluded for the year and all pending legislation dies. The Farm Bill essentially would take hemp off the federal controlled substances list which in turn should be an incredible boon for Cannabis based stocks in the market.   Active cannabis companies in the markets this week include Earth Science Tech, Inc. (OTC:ETST), Terra Tech Corp. (OTC:TRTC), Aurora Cannabis Inc. (NYSE:ACB), INSYS Therapeutics Inc. (NASDAQ:INSY), CV Sciences Inc. (OTC:CVSI).

 

Earth Science Tech, Inc. (OTCQB:ETST) BREAKING NEWS:  Earth Science Tech, an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, today announces successful in vitro analyses of gynecological samples collected using its new Hygee medical device.

 

Hygee™ is a discreet, wearable medical device that enables a woman to anonymously test for sexually transmitted infections (STIs). As previously announced, samples collected by the Hygee™ device are tested by Procréa and Dermagate. In pre-launch testing at the labs, molecular diagnostic assays successfully identified the presence of Chlamydia in test subjects, confirming earlier testing results.

 

ETST’s President, Director and Chairman Nickolas S. Tabraue states, “We are pleased to announce positive testing in the pre-launch phase of Hygee™, and would like to thank our carefully selected partners, Procréa and Dermagate, for a job well done. They are the guarantee of our success.”

 

ETST is on track to launch Hygee™ in early 2019. The Company plans to market the product through its established distribution channels, mentioned in November, thanks Dermagate’s ISO 13485:2013 certification.   “Hygee™ is an incredible innovation, and we have partners from many countries waiting to market the device,” stated ETST CEO and Chief Scientific Officer Dr. Michel Aube. “This is only the beginning of realizing the potential of this unique device, and we look forward to updating our shareholders on our progress.”     Read this and more news for ETST at https://www.financialnewsmedia.com/news-etst


Other recent developments in the cannabis industry include:

 

Terra Tech Corp. (OTCQX:TRTC) recently announced that its wholly-owned subsidiary, Edible Garden, will participate in the New York Produce Show and Conference, booth # 332, on Wednesday, December 12th in New York City. The conference is hosted by NY Produce and brings together 400 companies to learn, network, build relationships, and conduct business. Edible Garden will have an exhibit booth at the show displaying its range of natural products including the new Organics 4” Living Herbs collection, its ‘Snip Its™’ line of fresh cut herbs and its utility patented, nutritionally-enhanced SUPERLEAF™ lettuce, which was developed in partnership with Nutrasorb LLC, in conjunction with Rutgers University, and contains 2.5x as many antioxidants as blueberries and 5X more antioxidants than ordinary lettuce. Edible Garden fully expects to harvest a large amount of interest among industry enthusiasts based on its 100% natural, fresh and local product lines.

 

Aurora Cannabis Inc. (NYSE:ACB) earlier this week announced that that, further to the Company’s press release dated December 7, 2018 , the Company has entered into a Letter of Intent to acquire all of the issued and outstanding shares of Farmacias Magistrales S.A. (“Farmacias”), subject to customary due diligence provisions,  the completion of definitive agreements, and regulatory and government approval. As previously announced, Farmacias recently became Mexico’s first and only federally licensed importer to date of raw materials containing THC, gaining the necessary licenses, facilities, and permissions to import raw THC material, and manufacture, store, and distribute medical cannabis products containing over 1% THC. This transaction firmly establishes Aurora’s first-mover advantage in one of the world’s most populous countries, where more than 130 million people will have federally legal access to a range of Aurora’s non-flower medical cannabis products containing THC.

 

INSYS Therapeutics Inc. (NASDAQ:INSY) news: Pharmaceutical-grade cannabidiol (CBD) oral solution made by INSYS Therapeutics, Inc., a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, was generally well-tolerated—even at high doses—as an investigational treatment for refractory pediatric epilepsy, according to new clinical data from a long-term safety study presented at the American Epilepsy Society (AES) 2018 annual meeting. “The results of this study support the promising safety profile of CBD oral solution from INSYS in the context of treating pediatric patients with intractable seizures due to epilepsy,” said James W. Wheless, M.D., professor and chief of pediatric neurology at the University of Tennessee Health Science Center in Memphis, where he directs the Neuroscience Institute & Le Bonheur Comprehensive Epilepsy at Le Bonheur Children’s Hospital and holds the Le Bonheur Chair in Pediatric Neurology. “In addition, these long-term safety data are consistent with those from other studies of CBD in refractory pediatric epilepsy.”

 

CV Sciences Inc. (OTCQB:CVSI) recently announced it has received Nutritional Outlook’s 2018 Best of the Industry Awards, Retail/Brand Product, for the Company’s best-selling PlusCBD Oil™ line of hemp-derived CBD products. Editor-in-Chief Jennifer Grebow states, “In Nutritional Outlook’s 2018 Best of the Industry Awards, we are recognizing individuals, groups, and companies whose initiatives today may help shape, for the better, the state of the dietary supplement and food and beverage industries for years to come.”

 

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks..  For current services performed FNM has been compensated twenty six hundred dollars for news coverage of the current press releases issued by Earth Science Tech, Inc. by the company.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

 

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

Contact Information:

Media Contact email: editor@financialnewsmedia.com – +1(561)325-8757

 

SOURCE Financialnewsmedia.com

Sign Up & Get FREE News Alerts From FNM Today!